Knowing Your Family’s Surgical History Might Be Key To Preventing Emergency Gallbladder Surgery
People might attribute midnight bouts of chest pain or waves of nausea to food poisoning, stress or a stubborn case of indigestion, but Rutgers Health researchers suggest that knowing your family’s surgical past could pinpoint another cause: gallstone disease. Their study, published in the Journal of Surgical Research, found that patients who were aware of family members’ […]
Semaglutide helps manage metabolic side effects of antipsychotic drugs
Recent clinical research indicates that semaglutide may effectively reverse weight gain and blood sugar issues caused by certain antipsychotic medications. A randomized trial demonstrated that patients taking this drug experienced weight loss and improved metabolic health compared to those receiving a placebo. These findings were published in JAMA Psychiatry. People diagnosed with schizophrenia face a […]
The Ozempic Era Even Comes for adidas’ Post-Samba Sneakers
Another day, another delightfully slim adidas sneaker remade in the Samba’s image. Who’s complaining? The adidas Handball Spezial Lo Pro Core shoe takes a delightfully slim silhouette and makes it even skinnier. The GLP-1-ification of footwear continues. Like other members of adidas’ slim sneaker lineage, the Handball Spezial Lo Pro Core sneaker wears a low-profile […]
Pfizer adds heft to obesity pipeline in $2B Yaopharma deal
A month after besting rival Novo Nordisk A/S in a bidding war for obesity drug developer Metsera Inc., Pfizer Inc. is again adding to its GLP-1 arsenal, this time via a $2 billion licensing and collaboration agreement with Yaopharma, a subsidiary of China’s Fosun Pharmaceutical Co. Ltd.
Down 50%, Should You Buy the Dip on Pfizer?
Key Points Pfizer is one of the world’s largest drugmakers. It has long managed to produce new blockbuster drugs to replace drugs losing patent protection. In time, the company’s current patent cliff is likely to be resolved. 10 stocks we like better than Pfizer › Pfizer (NYSE: PFE) is deeply unloved today. There are a […]
Eli Lilly to make GLP-1 pill in US
CNN’s Erin Burnett speaks to Eli Lilly CEO David Ricks on major changes to weight-loss drugs and expanded manufacturing. Watch the full interview on Erin Burnett OutFront. #CNN #News
Breakthrough GLP-1 implant promises major weight-loss benefits for pets
The world’s first GLP-1 weight loss treatment is being administered for pets on an experimental basis. The first cat was successfully dosed in the MEOW-1 study of OKV-119 – an investigational “ultra-long acting” GLP-1 implant, which, according to a press release, is being developed for weight management in cats. OKAVA Pharmaceuticals, the San Francisco-based manufacturer […]
Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend
The rapid adoption of GLP-1 weight loss medications — drugs like Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Zepbound and Mounjaro — is reshaping how Americans eat and shop. It’s also changing how major corporations do business. From new product lines to expanding certain categories, companies are trying to capitalize on the lifestyle shifts […]
Darling Ingredients Inc. (DAR): A Bull Case Theory
We came across a bullish thesis on Darling Ingredients Inc. on Valueinvestorsclub.com by TallGuy. In this article, we will summarize the bulls’ thesis on DAR. Darling Ingredients Inc.’s share was trading at $37.01 as of December 2nd. DAR’s trailing and forward P/E were 54.88 and 11.07 respectively according to Yahoo Finance. Copyright: mikkolem / 123RF Stock Photo Darling […]
Eli Lilly earmarks $6B for GLP-1 pill factory in Alabama
Eli Lilly will spend $6 billion to build an orforglipron factory in Huntsville, AL, the third of four new US sites the pharma giant plans to announce this year. As well as manufacturing the oral …